BIOCONNSEBiocon Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 26 Mar · 18:08 IST

Biocon Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.1%1-day move
₹379.20
prior close
₹378.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.9-0.5-0.4-0.6-5.1-3.9-7.2-6.3-10.3-9.0-5.6-4.6+14.4+9.2
Up moveDown movePending
AI summary

Biocon Limited has informed the stock exchanges that its trading window for dealing in shares will remain closed from Wednesday, April 1, 2026, until 48 hours after the declaration of financial results for the quarter and year ending March 31, 2026. This closure is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own insider trading code. The date of the board meeting to approve the Q4 and FY26 financial results has not yet been announced and will be communicated separately.

Likely market impact

This is a routine regulatory compliance announcement with no direct impact on shareholders or stock price. However, the upcoming Q4 and FY26 results declaration could be a significant event for the stock. Insiders, including directors and designated employees, are prohibited from trading in Biocon shares during the closed window.